| Predicate |
Object |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2095 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-663
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-593
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2077
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-663
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-593 |
| filingDate |
2011-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2016-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2016-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-102946884-B |
| titleOfInvention |
For preventing or treating osteoporotic composition and method of making the same |
| abstract |
The present invention prevents or treats osteoporotic compositions open a kind of being used for, and described compositions comprises ibandronic acid, the acceptable salt of its pharmacy or its hydrate and vitamin D.Because by the processing of described ibandronic acid, the acceptable salt of its pharmacy or its hydrate to show the physical characteristic similar to vitamin D, described compositions ensures the even drug effect of preparation prepared therefrom. |
| priorityDate |
2010-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |